Long noncoding RNAs in digestive system malignancies: A novel class of cancer biomarkers and therapeutic targets?

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Kladi Skandali, Athina ^a   Michaelidou, Kleita ^a   Scorilas, Andreas ^a   Mavridis, Konstantinos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; TRANSCRIPTOME;

ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENESIS; CLINICAL PRACTICE; COLON CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIGESTIVE FUNCTION; DIGESTIVE SYSTEM CANCER; DRUG TARGETING; EARLY DIAGNOSIS; ESOPHAGUS CANCER; HUMAN; LIVER CANCER; MOLECULAR PATHOLOGY; NONHUMAN; PANCREAS CANCER; PREDICTIVE VALUE; REGULATORY MECHANISM; SERUM; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH JUICE; TRANSCRIPTOMICS; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE;

EID: 84929359726     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/319861     Document Type: Article

References (164)

1. J. Haringsma, N. C. M. Van Heel, and E. J. Kuipers, "Are we making progress in diagnosing and preventing gastrointestinal cancers?" Terapeutic Advances in Gastroenterology, vol. 3, no. 4, pp. 213-220, 2010.
2. J. Ferlay, I. Soerjomataram, R. Dikshit et al., "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", International Journal of Cancer, vol. 136, no. 5, pp. E359-E386, 2015.
3. Y. W. Sun, Y. F. Chen, J. Li et al., "A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma", British Journal of Cancer, vol. 111, no. 11, pp. 2131-2141, 2014.
4. X. B. D'Journo and P. A. Tomas, "Current management of esophageal cancer", Journal of Toracic Disease, vol. 6, supplement 2, pp. S253-S264, 2014.
5. M. L. Rossi, A. A. Rehman, and C. S. Gondi, "Terapeutic options for the management of pancreatic cancer", World Journal of Gastroenterology, vol. 20, no. 32, pp. 11142-11159, 2014.
6. S. Kasper and M. Schuler, "Targeted therapies in gastroesophageal cancer", European Journal of Cancer, vol. 50, no. 7, pp. 1247-1258, 2014.
7. J. W. Shin and Y.-H. Chung, "Molecular targeted therapy for hepatocellular carcinoma: current and future", World Journal of Gastroenterology, vol. 19, no. 37, pp. 6144-6155, 2013.
8. Y. Zheng, J. Zhou, and Y. Tong, "Gene signatures of drug resistance predict patient survival in colorectal cancer", Pharmacogenomics Journal, vol. 15, no. 2, pp. 135-143, 2014.
9. M. Pertea, "The human transcriptome: an unfnished story", Genes, vol. 3, no. 3, pp. 344-360, 2012.
10. J. Sana, P. Faltejskova, M. Svoboda, and O. Slaby, "Novel classes of non-coding RNAs and cancer", Journal of Translational Medicine, vol. 10, no. 1, article 103, 2012.
11. S. A. Slavof, A. J. Mitchell, A. G. Schwaid et al., "Peptidomic discovery of short open reading frame-encoded peptides in human cells", Nature Chemical Biology, vol. 9, no. 1, pp. 59-64, 2013.
12. A. Gardini and R. Shiekhattar, "The many faces of long noncoding RNAs", The FEBS Journal, 2014.
13. E. M. Reis and S. Verjovski-Almeida, "Perspectives of long noncoding RNAs in cancer diagnostics", Frontiers in Genetics, vol. 3, article 32, 2012.
14. T. Gutschner and S. Diederichs, "The hallmarks of cancer: a long non-coding RNA point of view", RNA Biology, vol. 9, no. 6, pp. 703-709, 2012.
15. E. A. Gibb, C. J. Brown, and W. L. Lam, "The functional role of long non-coding RNA in human carcinomas", Molecular Cancer, vol. 10, article 38, 2011.
16. L. Ma, V. B. Bajic, and Z. Zhang, "On the classification of long non-coding RNAs", RNA Biology, vol. 10, no. 6, pp. 925-933, 2013.
17. C. I. Brannan, E. C. Dees, R. S. Ingram, and S. M. Tilghman, "The product of the H19 gene may function as an RNA", Molecular and Cellular Biology, vol. 10, no. 1, pp. 28-36, 1990.
18. C. J. Brown, A. Ballabio, J. L. Rupert et al., "A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome", Nature, vol. 349, no. 6304, pp. 38-44, 1991.
19. C. Xie, J. Yuan, H. Li et al., "NONCODEv4: exploring the world of long non-coding RNA genes", Nucleic Acids Research, vol. 42, no. 1, pp. D98-D103, 2014.
20. O. Wapinski and H. Y. Chang, "Long noncoding RNAs and human disease", Trends in Cell Biology, vol. 21, no. 6, pp. 354-361, 2011.
21. M. Sun and W. Lee Kraus, "Minireview: long noncoding RNAs: new links between gene expression and cellular outcomes in endocrinology", Molecular Endocrinology, vol. 27, no. 9, pp. 1390-1402, 2013.
22. J. R. Prensner and A. M. Chinnaiyan, "The emergence of lncRNAs in cancer biology", Cancer Discovery, vol. 1, no. 5, pp. 391-407, 2011.
23. C. P. Ponting, P. L. Oliver, and W. Reik, "Evolution and functions of long noncoding RNAs", Cell, vol. 136, no. 4, pp. 629-641, 2009.
24. E. S. Martens-Uzunova, R. Böttcher, C. M. Croce, G. Jenster, T. Visakorpi, and G. A. Calin, "Long noncoding RNA in prostate, bladder, and kidney cancer", European Urology, vol. 65, no. 6, pp. 1140-1151, 2014.
25. A. Fatica and I. Bozzoni, "Long non-coding RNAs: new players in cell differentiation and development", Nature Reviews Genetics, vol. 15, no. 1, pp. 7-21, 2014.
26. J. R. Alvarez-Dominguez, W. Hu, and H. F. Lodish, "Regulation of eukaryotic cell differentiation by long non-coding RNAs", in Molecular Biology of Long Non-coding RNAs, A. M. Khalil and J. Coller, Eds., pp. 15-67, Springer, New York, NY, USA, 2013.
27. C. Wahlestedt, "Targeting long non-coding RNA to therapeutically upregulate gene expression", Nature Reviews Drug Discovery, vol. 12, no. 6, pp. 433-446, 2013.
28. J. Li, Z. Xuan, and C. Liu, "Long non-coding RNAs and complex human diseases", International Journal of Molecular Sciences, vol. 14, no. 9, pp. 18790-18808, 2013.
29. M. Hajjari, A. Khoshnevisan, and Y. K. Shin, "Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer", Tumor Biology, vol. 35, no. 11, pp. 10645-10663, 2014.
30. R. A. Gupta, N. Shah, K. C. Wang et al., "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis", Nature, vol. 464, no. 7291, pp. 1071-1076, 2010.
31. Z.-Y. Xu, Q.-M. Yu, Y.-A. Du et al., "Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer", International Journal of Biological Sciences, vol. 9, no. 6, pp. 587-597, 2013.
32. J. T. Serviss, P. Johnsson, and D. Grandér, "An emerging role for long non-coding RNAs in cancer metastasis", Frontiers in Genetics, vol. 5, 2014.
33. C. N. Niland, C. R. Merry, and A. M. Khalil, "Emerging roles for long non-coding RNAs in cancer and neurological disorders", Frontiers in Genetics, 2012.
34. T. Kino, D. E. Hurt, T. Ichijo, N. Nader, and G. P. Chrousos, "Noncoding RNA Gas5 is a growth arrest- and starvationassociated repressor of the glucocorticoid receptor", Science Signaling, vol. 3, no. 107, p. ra8, 2010.
35. G. L. Lee, A. Dobi, and S. Srivastava, "Prostate cancer: diagnostic performance of the PCA3 urine test", Nature Reviews Urology, vol. 8, no. 3, pp. 123-124, 2011.
36. J. R. Day, M. Jost, M. A. Reynolds, J. Groskopf, and H. Rittenhouse, "PCA3: from basic molecular science to the clinical lab", Cancer Letters, vol. 301, no. 1, pp. 1-6, 2011.
37. X.-S. Wang, Z. Zhang, H.-C. Wang et al., "Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma", Clinical Cancer Research, vol. 12, no. 16, pp. 4851-4858, 2006.
38. H. Zhang, Z. Chen, X. Wang, Z. Huang, Z. He, and Y. Chen, "Long non-coding RNA: a new player in cancer", Journal of Hematology and Oncology, vol. 6, no. 1, article 37, 2013.
39. J. Fellenberg, L. Bernd, G. Delling, D. Witte, and A. Zahlten-Hinguranage, "Prognostic significance of drug-regulated genes in high-grade osteosarcoma", Modern Pathology, vol. 20, no. 10, pp. 1085-1094, 2007.
40. M. C. Smaldone and B. J. Davies, "BC-819, aplasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers", Current Opinion in Molecular Terapeutics, vol. 12, no. 5, pp. 607-616, 2010.
41. A. A. Sidi, P. Ohana, S. Benjamin et al., "Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus calmette-guerin", Journal of Urology, vol. 180, no. 6, pp. 2379-2383, 2008.
42. H. Ling, M. Fabbri, and G. A. Calin, "MicroRNAs and other non-coding RNAs as targets for anticancer drug development", Nature Reviews Drug Discovery, vol. 12, no. 11, pp. 847-865, 2013.
43. F. Yang, X. Xue, L. Zheng et al., "Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability", FEBS Journal, vol. 281, no. 3, pp. 802-813, 2014.
44. I. Matouk, E. Raveh, P. Ohana et al., "The increasing complexity of the oncofetal H19 gene locus: functional dissection and therapeutic intervention", International Journal of Molecular Sciences, vol. 14, no. 2, pp. 4298-4316, 2013.
45. W. P. Tsang, E. K. O. Ng, S. S. M. Ng et al., "Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer", Carcinogenesis, vol. 31, no. 3, pp. 350-358, 2010.
46. F. Yang, J. Bi, X. Xue et al., "Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells", FEBS Journal, vol. 279, no. 17, pp. 3159-3165, 2012.
47. E.-B. Zhang, L. Han, D.-D. Yin, R. Kong, W. De, and J. Chen, "c-Myc-induced, long, noncoding H19 afects cell proliferation and predicts a poor prognosis in patients with gastric cancer", Medical Oncology, vol. 31, article 914, 2014.
48. X. He, X. Tan, X. Wang et al., "C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion", Tumor Biology, vol. 35, no. 12, pp. 12181-12188, 2014.
49. T. Kim, R. Cui, Y.-J. Jeon et al., "Long-range interaction and correlation between MYC enhancer and oncogenic longnoncoding RNA CARLo-5", Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 11, pp. 4173-4178, 2014.
50. Y. Zhang, M. Ma, W. Liu, W. Ding, and H. Yu, "Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer", International Journal of Clinical & Experimental Pathology, vol. 7, no. 12, pp. 8471-8479, 2014.
51. F. Yang, L. Zhang, X.-S. Huo et al., "Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans", Hepatology, vol. 54, no. 5, pp. 1679-1689, 2011.
52. K. Panzitt, M. M. O. Tschernatsch, C. Guelly et al., "Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA", Gastroenterology, vol. 132, no. 1, pp. 330-342, 2007.
53. Y. Du, G. Kong, X. You et al., "Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18", Journal of Biological Chemistry, vol. 287, no. 31, pp. 26302-26311, 2012.
54. J. Wang, X. Liu, H. Wu et al., "CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer", Nucleic Acids Research, vol. 38, no. 16, pp. 5366-5383, 2010.
55. Y. Takahashi, G. Sawada, J. Kurashige et al., "Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers", British Journal of Cancer, vol. 110, no. 1, pp. 164-171, 2014.
56. J. Wang, L. Su, X. Chen et al., "MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF", Biomedicine and Pharmacotherapy, vol. 68, no. 5, pp. 557-564, 2014.
57. M. Sun, F.-Y. Jin, R. Xia et al., "Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer", BMC Cancer, vol. 14, no. 1, article 319, 2014.
58. X. Lu, Y. Fang, Z. Wang et al., "Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6", Cell and This sue Research, vol. 354, no. 3, pp. 891-896, 2013.
59. M. Sun, R. Xia, F. Jin et al., "Downregulated long noncoding RNA MEG3isassociated withpoorprognosis and promotes cell proliferation in gastric cancer", Tumor Biology, vol. 35, no. 2, pp. 1065-1073, 2014.
60. D. Yin, Z. Liu, E. Zhang, R. Kong, Z. Zhang, and R. Guo, "Decreased expression of long noncoding RNA MEG3 afects cell proliferation and predicts a poor prognosis in patients with colorectal cancer", Tumor Biology, 2015.
61. Y. Zhou, Y. Zhong, Y. Wang et al., "Activation of p53 by MEG3 non-coding RNA", The Journal of Biological Chemistry, vol. 282, no. 34, pp. 24731-24742, 2007.
62. C. Braconi, T. Kogure, N. Valeri et al., "MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer", Oncogene, vol. 30, no. 47, pp. 4750-4756, 2011.
63. J. Yan, X. Guo, J. Xia et al., "MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1", Medical Oncology, vol. 31, no. 3, article 879, 2014.
64. Q. Liu, J. Huang, N. Zhou et al., "LncRNA loc285194 is a p53-regulated tumor suppressor", Nucleic Acids Research, vol. 41, no. 9, pp. 4976-4987, 2013.
65. R. Kogo, T. Shimamura, K. Mimori et al., "Long noncoding RNA HOTAIR regulates polycomb-dependentchromatin modification and is associated with poor prognosis in colorectal cancers", Cancer Research, vol. 71, no. 20, pp. 6320-6326, 2011.
66. C. Ding, S. Cheng, Z. Yang et al., "Long non-coding RNA HOTAIR promotes cell migration and invasion via downregulation of RNA binding motif protein 38 in hepatocellular carcinoma cells", International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4060-4076, 2014.
67. Y. J. Geng, S. L. Xie, Q. Li, J. Ma, and G. Y. Wang, "Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression", Journal of International Medical Research, vol. 39, no. 6, pp. 2119-2128, 2011.
68. X.-H. Liu, M. Sun, F.-Q. Nie et al., "Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer", Molecular Cancer, vol. 13, no. 1, article 92, 2014.
69. M. Z. Ma, C. X. Li, Y. Zhang et al., "Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer", Molecular Cancer, vol. 13, no. 1, article 156, 2014.
70. Q. Ji, L. Zhang, X. Liu et al., "Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex", British Journal of Cancer, vol. 111, no. 4, pp. 736-748, 2014.
71. M. H. Yang, Z. Y. Hu, C. Xu et al., "MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9", Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1852, no. 1, pp. 166-174, 2015.
72. H. Ling, R. Spizzo, Y. Atlasi et al., "CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer", Genome Research, vol. 23, no. 9, pp. 1446-1461, 2013.
73. I. J. Matouk, N. De Groot, S. Mezan et al., "The H19 non-coding RNA is essential for human tumor growth", PLoS ONE, vol. 2, no. 9, article e845, 2007.
74. L. Zhang, F. Yang, J.-H. Yuan et al., "Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma", Carcinogenesis, vol. 34, no. 3, pp. 577-586, 2013.
75. F. Yang, X.-S. Huo, S.-X. Yuan et al., "Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis", Molecular Cell, vol. 49, no. 6, pp. 1083-1096, 2013.
76. J. F. Huang, Y. J. Guo, C. X. Zhao et al., "Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) downregulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate flament protein vimentin", Hepatology, vol. 57, no. 5, pp. 1882-1892, 2013.
77. Y. Han, J. Ye, D. Wu et al., "LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition", BMC Cancer, vol. 14, no. 1, p. 932, 2014.
78. L. D. Graham, S. K. Pedersen, G. S. Brown et al., "Colorectal neoplasia differentially expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas", Genes and Cancer, vol. 2, no. 8, pp. 829-840, 2011.
79. B. Yan, W. Gu, Z. Yang et al., "Downregulation of a long noncoding RNA-ncRuPAR contributes to tumor inhibition in colorectal cancer", Tumor Biology, vol. 35, no. 11, pp. 11329-11335, 2014.
80. A. Nissan, A. Stojadinovic, S. Mitrani-Rosenbaum et al., "Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues", International Journal of Cancer, vol. 130, no. 7, pp. 1598-1606, 2012.
81. B. Alaiyan, N. Ilyayev, A. Stojadinovic et al., "Diferential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence", BMC Cancer, vol. 13, article 196, 2013.
82. Y. Kam, A. Rubinstein, S. Naik et al., "Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons", Cancer Letters, vol. 352, no. 1, pp. 90-96, 2014.
83. L. Li, R. Sun, Y. Liang et al., "Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer", Journal of Experimental and Clinical Cancer Research, vol. 32, no. 1, article 104, 2013.
84. Y. Xue, D. Gu, G. Ma et al., "Genetic variants in lncRNA HOTAIR are associated with risk of colorectal cancer", Mutagenesis, vol. 30, no. 2, pp. 303-310, 2015.
85. Z. Wu, X. Wang, H. Tang et al., "Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer", Oncology Reports, vol. 32, no. 1, pp. 395-402, 2014.
86. M. Svoboda, J. Slyskova, M. Schneiderova et al., "HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients", Carcinogenesis, vol. 35, no. 7, pp. 1510-1515, 2014.
87. H.-T. Zheng, D.-B. Shi, Y.-W. Wang et al., "High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer", International Journal of Clinical & Experimental Pathology, vol. 7, no. 6, pp. 3174-3181, 2014.
88. Y. Han, Y. N. Yang, H. H. Yuan et al., "UCA1, a long noncoding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution", Pathology, vol. 46, no. 5, pp. 396-401, 2014.
89. X. Ge, Y. Chen, X. Liao et al., "Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer", Medical Oncology, vol. 30, no. 2, article 588, 2013.
90. Q. Deng, B. He, T. Gao et al., "Up-regulation of 91H promotes tumor metastasis and predicts poor prognosis for patients with colorectal cancer", PLoS ONE, vol. 9, no. 7, Article ID e103022, 2014.
91. Q. Guo, Y. Zhao, J. Chen et al., "BRAF-activated long noncoding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition", Oncology Letters, vol. 8, no. 2, pp. 869-875, 2014.
92. M. D. Xu, P. Qi, W. W. Weng et al., "Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cance", Medicine, vol. 93, no. 28, article e303, 2014.
93. P. Qi, M.-D. Xu, S.-J. Ni et al., "Low expression of LOC285194 is associated with poor prognosis in colorectal cancer", Journal of Translational Medicine, vol. 11, no. 1, article 122, 2013.
94. P. Qi, M.-D. Xu, S.-J. Ni et al., "Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients", Molecular Carcinogenesis, 2014.
95. D. Shi, H. Zheng, C. Zhuo et al., "Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer", Medical Oncology, vol. 31, no. 7, p. 31, 2014.
96. J. Sana, S. Hankeova, M. Svoboda, I. Kiss, R. Vyzula, and O. Slaby, "Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer", Oncology, vol. 82, no. 2, pp. 114-118, 2012.
97. D. Yin, X. He, E. Zhang, R. Kong, W. De, and Z. Zhang, "Long noncoding RNA GAS5 afects cell proliferation and predicts a poor prognosis in patients with colorectal cancer", Medical Oncology, vol. 31, no. 11, article 253, 2014.
98. Y. Hu, H.-Y. Chen, C.-Y. Yu et al., "A long non-coding RNA signature to improve prognosis prediction of colorectal cancer", Oncotarget, vol. 5, no. 8, pp. 2230-2242, 2014.
99. Y. Okugawa, Y. Toiyama, K. Hur et al., "Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis", Carcinogenesis, vol. 35, no. 12, pp. 2731-2739, 2014.
100. N. K. Lee, J. H. Lee, C. H. Park et al., "Long non-coding RNA HOTAIR promotes carcinogenesis and invasion of gastric adenocarcinoma", Biochemical and Biophysical Research Communications, vol. 451, no. 2, pp. 171-178, 2014.
101. E. Emadi-Andani, P. Nikpour, M. Emadi-Baygi, and A. Bidmeshkipour, "Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis", Advanced Biomedical Research, vol. 3, no. 1, article 135, 2014.
102. H. Endo, T. Shiroki, T. Nakagawa et al., "Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer", PLoS ONE, vol. 8, no. 10, Article ID e77070, 2013.
103. M. Hajjari, M. Behmanesh, M. Sadeghizadeh, and M. Zeinoddini, "Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues", Medical Oncology, vol. 30, no. 3, article 670, 2013.
104. H. Li, B. Yu, J. Li et al., "Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer", Oncotarget, vol. 5, no. 8, pp. 2318-2329, 2014.
105. E.-B. Zhang, R. Kong, D.-D. Yin et al., "Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a", Oncotarget, vol. 5, no. 8, pp. 2276-2292, 2014.
106. Y. Zhao, Q. Guo, J. Chen, J. Hu, S. Wang, and Y. Sun, "Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation", Oncology Reports, vol. 31, no. 1, pp. 358-364, 2014.
107. X. Lin, M. Yang, T. Xia, and J. Guo, "Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance", Medical Oncology, vol. 31, article 42, 2014.
108. J. Ding, D. Li, M. Gong et al., "Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer", OncoTargets and Terapy, vol. 2014, article 7, pp. 1625-1630, 2014.
109. X. Chen, J. Sun, Y. Song et al., "The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer", Medical Oncology, vol. 31, no. 11, p. 262, 2014.
110. Y. Shao, M. Ye, X. Jiang et al., "Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer", Cancer, vol. 120, no. 21, pp. 3320-3328, 2014.
111. T. P. Xu, M. D. Huang, R. Xia et al., "Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by afecting fbronectin1 expression", Journal of Hematology & Oncology, vol. 7, no. 1, article 63, 2014.
112. W. Sun, Y. Wu, X. Yu et al., "Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance", Tumor Biology, vol. 34, no. 5, pp. 2697-2701, 2013.
113. Z. Liu, Y. Shao, L. Tan, H. Shi, S. Chen, and J. Guo, "Clinical significance of the low expression of FER1L4 in gastric cancer patients", Tumor Biology, vol. 35, no. 10, pp. 9613-9617, 2014.
114. T. Arita, D. Ichikawa, H. Konishi et al., "Circulating long non-coding RNAs in plasma of patients with gastric cancer", Anticancer Research, vol. 33, no. 8, pp. 3185-3193, 2013.
115. Q. Pang, J. Ge, Y. Shao et al., "Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance", Tumor Biology, vol. 35, no. 6, pp. 5441-5447, 2014.
116. W.-J. Cao, H.-L. Wu, B.-S. He, Y.-S. Zhang, and Z.-Y. Zhang, "Analysis of long non-coding RNA expression profles in gastric cancer", World Journal of Gastroenterology, vol. 19, no. 23, pp. 3658-3664, 2013.
117. H. Song, W. Sun, G. Ye et al., "Long non-coding RNA expression profle in human gastric cancer and its clinical significances", Journal of Translational Medicine, vol. 11, no. 1, p. 225, 2013.
118. I. Mizrahi, H. Mazeh, R. Grinbaum et al., "Colon cancer associated transcript-1 (CCAT1) expression in adenocarcinoma of the stomach", Journal of Cancer, vol. 6, no. 2, pp. 105-110, 2015.
119. F. Yang, X. Xue, J. Bi et al., "Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma", Journal of Cancer Research and Clinical Oncology, vol. 139, no. 3, pp. 437-445, 2013.
120. C. Y. Wang, L. Hua, K. H. Yao, J. T. Chen, J. J. Zhang, and J. H. Hu, "Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis", International Journal of Clinical and Experimental Pathology, vol. 8, no. 1, pp. 779-785, 2015.
121. B. Zhou, X.-Y. Jing, J.-Q. Wu, H.-F. Xi, and G.-J. Lu, "Downregulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer", International Journal of Clinical & Experimental Patholog, vol. 7, no. 12, pp. 8893-8898, 2014.
122. S.-M. Park, S.-J. Park, H.-J. Kim et al., "A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis", Experimental and Molecular Medicine, vol. 45, no. 7, article e31, 2013.
123. H. Xie, H. Ma, and D. Zhou, "Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma", BioMed Research International, vol. 2013, Article ID 136106, 5 pages, 2013.
124. J. Lu, F. Xie, L. Geng, W. Shen, C. Sui, and J. Yang, "Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profle in patients with hepatocellular carcinoma and HBV", Tumor Biology, 2014.
125. J. Zhao, C. M. Greene, S. G. Gray, and M. W. Lawless, "Long noncoding RNAs in liver cancer: what we know in 2014", Expert Opinion on Terapeutic Targets, vol. 18, no. 10, pp. 1207-1218, 2014.
126. J. Zhu, S. Liu, F. Ye et al., "The long noncoding RNA expression profle of hepatocellular carcinoma identified by microarray analysis", PLoS ONE, vol. 9, no. 7, Article ID e101707, 2014.
127. M. Ishibashi, R. Kogo, K. Shibata et al., "Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma", Oncology Reports, vol. 29, no. 3, pp. 946-950, 2013.
128. S.-X. Yuan, F. Yang, Y. Yang et al., "Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival afer hepatectomy", Hepatology, vol. 56, no. 6, pp. 2231-2241, 2012.
129. W. H. Xu, J. B. Zhang, Z. Dang et al., "Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma", International Journal of Biological Sciences, vol. 10, no. 7, pp. 664-676, 2014.
130. J.-H. Yuan, F. Yang, F. Wang et al., "A long noncoding RNA Activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma", Cancer Cell, vol. 25, no. 5, pp. 666-681, 2014.
131. L. Quagliata, M. S. Matter, S. Piscuoglio et al., "Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients", Hepatology, vol. 59, no. 3, pp. 911-923, 2014.
132. C. Ding, Z. Yang, Z. Lv et al., "Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients", Oncology Letters, vol. 9, no. 2, pp. 955-963, 2015.
133. Z.-Q. Tu, R.-J. Li, J.-Z. Mei, and X.-H. Li, "Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma", International Journal of Clinical & Experimental Pathology, vol. 7, no. 7, pp. 4303-4309, 2014.
134. J.-H. Liu, G. Chen, Y.-W. Dang, C.-J. Li, and D.-Z. Luo, "Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues", Asian Pacific Journal of Cancer Prevention, vol. 15, no. 7, pp. 2971-2977, 2014.
135. E. J. Pang, R. Yang, X. B. Fu, and Y. F. Liu, "Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer", Tumor Biology, vol. 36, no. 4, pp. 2403-2407, 2015.
136. K. Kim, I. Jutooru, G. Chadalapaka et al., "HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer", Oncogene, vol. 32, no. 13, pp. 1616-1625, 2013.
137. C. S. Huang, W. Yu, H. Cui et al., "Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients", Minerva Medica, vol. 10, p. 10, 2015.
138. J. Li, D. Liu, R. Hua et al., "Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC", Pancreatology, vol. 14, no. 5, pp. 385-390, 2014.
139. A. C. Tahira, M. S. Kubrusly, M. F. Faria et al., "Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer", Molecular Cancer, vol. 10, article 141, 2011.
140. C. Ma, K. Nong, H. Zhu et al., "H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT", Tumor Biology, vol. 35, no. 9, pp. 9163-9169, 2014.
141. D. Chen, Z. Zhang, C. Mao et al., "ANRIL inhibits p15INK4b through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma", Cellular Immunology, vol. 289, no. 1-2, pp. 91-96, 2014.
142. W. Li, J. Zheng, J. Deng et al., "Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells", Gastroenterology, vol. 146, no. 7, pp. 1714.e5-1726.e5, 2014.
143. Y. S. Tong, X. W. Wang, X. L. Zhou et al., "Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma", Molecular Cancer, vol. 14, no. 1, article 3, 2015.
144. H. Wu, J. Zheng, J. Deng et al., "A genetic polymorphism in lincRNA-uc003opf.1 is associated with susceptibility to esophageal squamous cell carcinoma in Chinese populations", Carcinogenesis, vol. 34, no. 12, pp. 2908-2917, 2013.
145. X. Yang, J. H. Song, Y. Cheng et al., "Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells", Gut, vol. 63, no. 6, pp. 881-890, 2014.
146. W. Wu, T. D. Bhagat, X. Yang et al., "Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma", Gastroenterology, vol. 144, no. 5, pp. 956.e4-966.e4, 2013.
147. M. Fassan, L. Dall'Olmo, M. Galasso et al., "Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis", Oncotarget, vol. 5, no. 16, pp. 7162-7171, 2014.
148. X.-S. Ge, H.-J. Ma, X.-H. Zheng et al., "HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway", Cancer Science, vol. 104, no. 12, pp. 1675-1682, 2013.
149. F. Chen, M. Sun, S. Li et al., "Upregulation of the long non-coding rna hotair promotes esophageal squamous cell carcinoma metastasis and poor prognosis", Molecular Carcinogenesis, vol. 52, no. 11, pp. 908-915, 2013.
150. F. Pan, J. Yao, Y. Chen et al., "A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predictpoor prognosisin esophageal squamous cell carcinoma", International Journal of Clinical & Experimental Pathology, vol. 7, no. 6, pp. 2838-2849, 2014.
151. J. Y. Li, X. Ma, and C. B. Zhang, "Overexpression of long noncoding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma", International Journal of Clinical and Experimental Pathology, vol. 7, no. 11, pp. 7938-7944, 2014.
152. H.-W. Xie, Q.-Q. Wu, B. Zhu et al., "Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis", Tumor Biology, vol. 35, no. 8, pp. 7743-7754, 2014.
153. W.-H. Shi, Q.-Q. Wu, S.-Q. Li et al., "Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma", Tumor Biology, vol. 36, no. 4, pp. 2501-2507, 2015.
154. W. Zang, T. Wang, J. Huang et al., "Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells", Cancer Gene Terapy, vol. 22, no. 3, pp. 138-144, 2015.
155. Y. Xu, J. Wang, M. Qiu et al., "Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma", Tumor Biology, vol. 36, no. 3, pp. 1643-1651, 2015.
156. C. Wang, Q. Wu, S. Li et al., "Upregulation of the long noncoding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage", Digestive Diseases and Sciences, vol. 59, no. 3, pp. 591-597, 2014.
157. T. Gao, B. He, Y. Pan et al., "Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression", Molecular Carcinogenesis, vol. 54, no. 5, pp. 359-367, 2015.
158. Y. S. Tong, X. L. Zhou, X. W. Wang et al., "Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma", Journal of Translational Medicine, vol. 12, article 233, 2014.
159. Y. Wang, D. Zhang, K. Wu, Q. Zhao, Y. Nie, and D. Fan, "Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines", Molecular and Cellular Biology, vol. 34, no. 17, pp. 3182-3193, 2014.
160. H. Lee, C. Kim, J. L. Ku et al., "A long non-coding RNA snaR contributes to 5-fuorouracil resistance in human colon cancer cells", Molecules and Cells, vol. 37, no. 7, pp. 540-546, 2014.
161. W. P. Tsang and T. T. Kwok, "Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells", Oncogene, vol. 26, no. 33, pp. 4877-4881, 2007.
162. L. You, D. Chang, H.-Z. Du, and Y.-P. Zhao, "Genome-wide screen identifes PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells", Biochemical and Biophysical Research Communications, vol. 407, no. 1, pp. 1-6, 2011.
163. Y. He, X.-M. Meng, C. Huang et al., "Long noncoding RNAs: novel insights into hepatocelluar carcinoma", Cancer Letters, vol. 344, no. 1, pp. 20-27, 2014.
164. N. Hanna, P. Ohana, F. M. Konikof et al., "Phase 1/2a, doseescalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer", Cancer Gene Terapy, vol. 19, no. 6, pp. 374-381, 2012.